5
Clinical Trials associated with QL1203(Qilu Pharmaceutical Co., Ltd.)A Randomized, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of QL1203 and Placebo Respectively Combined With Chemotherapy in Patients With Metastatic Colorectal Cancer
The purpose of this study is to determine the treatment effect of QL1203 in combination with mFOLFOX6 compared to Placebo in combination with mFOLFOX6 as first line therapy for metastatic colorectal cancer.
QL1203联合mFOLFOX6对比安慰剂联合mFOLFOX6 RAS野生型的转移性结直肠癌患者的有效性和安全性Ⅲ期临床研究
[Translation] Phase III clinical study on the efficacy and safety of QL1203 combined with mFOLFOX6 versus placebo combined with mFOLFOX6 in patients with RAS wild-type metastatic colorectal cancer
评价QL1203联合mFOLFOX6对比安慰剂联合mFOLFOX6一线治疗RAS野生型的转移性结直肠癌患者的有效性和安全性。
[Translation] To evaluate the efficacy and safety of QL1203 combined with mFOLFOX6 versus placebo combined with mFOLFOX6 as first-line treatment for patients with RAS wild-type metastatic colorectal cancer.
A Randomized, Double-blind and Single-dose Study to Compare the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Male Subjects.
A randomized, double-blind and parallel group study to compare the pharmacokinetic and safety of QL1203 and Vectibix® in healthy males.
100 Clinical Results associated with QL1203(Qilu Pharmaceutical Co., Ltd.)
100 Translational Medicine associated with QL1203(Qilu Pharmaceutical Co., Ltd.)
100 Patents (Medical) associated with QL1203(Qilu Pharmaceutical Co., Ltd.)
100 Deals associated with QL1203(Qilu Pharmaceutical Co., Ltd.)